Long‐term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study.
Saved in:
| Title: | Long‐term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study. |
|---|---|
| Authors: | Khalafallah, A. A.1,2 alhossain.khalafallah@utas.edu.au, Slancar, M.3, Cosolo, W.4, Abdi, E.5, Chern, B.6, Woodfield, R. J.7, Copeman, M. C.8 |
| Source: | European Journal of Cancer Care. Mar2018, Vol. 27 Issue 2, p1-1. 9p. 5 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09615423 |
|---|---|
| DOI: | 10.1111/ecc.12638 |
